Morgan Stanley lifts Oracle target ahead of analyst day, flags margin risks

Go back to Morgan Stanley lifts Oracle target ahead of analyst day, flags margin risks

Oppenheimer Keeps Perform Rating on Oracle (ORCL): 'a step-up in Capex expense to support the RPO growth is consuming all the free cash flow generation'

September 10, 2025 6:32 AM EDT

Oppenheimer analyst Brian Schwartz reiterated a Perform rating on Oracle (NYSE: ORCL).

The analyst comments "Oracle's business got off to a fast start in FY26 with accelerating top-line growth and a record sales performance across RPO, Cloud Revenue, OCI, and multi-cloud... More